Orbimed Advisors LLC Pmv Pharmaceuticals, Inc. Transaction History
Orbimed Advisors LLC
- $2.8 Billion
- Q2 2025
A detailed history of Orbimed Advisors LLC transactions in Pmv Pharmaceuticals, Inc. stock. As of the latest transaction made, Orbimed Advisors LLC holds 6,475,291 shares of PMVP stock, worth $8.94 Million. This represents 0.25% of its overall portfolio holdings.
Number of Shares
6,475,291
Previous 6,475,291
-0.0%
Holding current value
$8.94 Million
Previous $7.06 Million
2.76%
% of portfolio
0.25%
Previous 0.22%
Shares
4 transactions
Others Institutions Holding PMVP
# of Institutions
61Shares Held
37.6MCall Options Held
100Put Options Held
0-
Bml Capital Management, LLC Zionsville, IN5MShares$6.9 Million4.01% of portfolio
-
Sio Capital Management, LLC New York, NY3.74MShares$5.15 Million1.89% of portfolio
-
Arrow Mark Colorado Holdings LLC Denver, CO3.19MShares$4.4 Million0.07% of portfolio
-
Euclidean Capital LLC New York, NY2.63MShares$3.63 Million0.92% of portfolio
-
Alkeon Capital Management LLC New York, NY2.34MShares$3.23 Million0.0% of portfolio
About PMV Pharmaceuticals, Inc.
- Ticker PMVP
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 45,622,600
- Market Cap $63M
- Description
- PMV Pharmaceuticals, Inc., a precision oncology company, engages in the discovery and development of small molecule and tumor-agnostic therapies for p53 mutations in cancer. The company's lead product candidate is PC14586, a small molecule that corrects a p53 protein containing the Y220C mutation and restores wild-type p53 function. It is also d...